Emerging Technologies in Continuous IOP Monitoring - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Emerging Technologies in Continuous IOP Monitoring

Wearable and implantable devices offer new data on pressure variability, though barriers to routine use persist.

  • By

  • Khushi Saigal, BA

  • Rachel Chapman

  • Samantha Goldburg, MD

  • Mary Qiu, MD,

  • May 1, 2026

  • 22 min

Share

  • 1

    Wearable and implantable devices enhance continuous intraocular pressure (IOP) monitoring, addressing limitations of traditional tonometry.

  • 2

    Continuous monitoring technologies can detect diurnal and nocturnal IOP fluctuations, improving risk stratification in glaucoma management.

  • 3

    The Sensimed Triggerfish is a widely studied contact lens-based sensor that captures IOP changes during daily activities, correlating well with standard tonometry.

  • 4

    Implantable bioMEMS sensors, such as the Eyemate-IO, enable long-term IOP monitoring but require surgical implantation and have associated risks.

  • 5

    Both CLBS and bioMEMS devices show promise for individualized treatment strategies, though challenges like measurement drift and calibration persist.

Original Source(s)

Emerging Technologies in Continuous IOP Monitoring

  • by Khushi Saigal, BA, Rachel Chapman, Samantha Goldburg, MD, Mary Qiu, MD,

  • May 1, 2026

Related Content

The Hormonal Link to Ocular Disease in Women

Neda Gioia, OD, CNS, FMCP, FOWNS, reviewed how levels of individual hormones and the balance between them help regulate tear production, inflammation, wound healing, lipid secretion, intraocular pressure (IOP), and neuroprotection, and therefore can result in a higher burden of dry eye, glaucoma, or retinal disease in women.

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.

Red-green disease: overreliance on color-coded OCT RNFL analysis in glaucoma diagnosis